Ethic Inc. Has $2.07 Million Stake in STERIS plc $STE

Ethic Inc. boosted its holdings in STERIS plc (NYSE:STE) by 388.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,378 shares of the medical equipment provider’s stock after buying an additional 6,662 shares during the period. Ethic Inc.’s holdings in STERIS were worth $2,073,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Norges Bank acquired a new position in shares of STERIS in the 2nd quarter valued at $289,132,000. Orbis Allan Gray Ltd grew its stake in shares of STERIS by 36.0% during the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after purchasing an additional 556,088 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in STERIS by 55.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,520,479 shares of the medical equipment provider’s stock valued at $344,617,000 after purchasing an additional 540,999 shares during the last quarter. Invesco Ltd. increased its holdings in STERIS by 32.2% in the second quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock valued at $293,236,000 after purchasing an additional 297,076 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in STERIS by 305.9% in the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock valued at $81,880,000 after buying an additional 249,386 shares during the period. 94.69% of the stock is owned by institutional investors.

STERIS Price Performance

Shares of STE opened at $253.55 on Friday. The stock has a 50 day simple moving average of $255.29 and a 200 day simple moving average of $244.93. STERIS plc has a 52-week low of $200.98 and a 52-week high of $268.60. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37. The firm has a market capitalization of $24.89 billion, a PE ratio of 36.43 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same quarter in the previous year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Sell-side analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were paid a $0.63 dividend. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio is presently 36.21%.

Insider Transactions at STERIS

In other STERIS news, VP Julia Madsen sold 5,008 shares of STERIS stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the sale, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. This trade represents a 31.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the sale, the vice president owned 5,695 shares in the company, valued at approximately $1,466,747.25. This trade represents a 46.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 25,203 shares of company stock worth $6,624,667 in the last 90 days. Company insiders own 1.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on STE shares. Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $273.50.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.